Thomas Notter

604 total citations
6 papers, 477 citations indexed

About

Thomas Notter is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and General Health Professions. According to data from OpenAlex, Thomas Notter has authored 6 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Physiology and 1 paper in General Health Professions. Recurrent topics in Thomas Notter's work include Nitric Oxide and Endothelin Effects (3 papers), Heart Failure Treatment and Management (3 papers) and Cardiovascular Function and Risk Factors (2 papers). Thomas Notter is often cited by papers focused on Nitric Oxide and Endothelin Effects (3 papers), Heart Failure Treatment and Management (3 papers) and Cardiovascular Function and Risk Factors (2 papers). Thomas Notter collaborates with scholars based in Germany, Switzerland and United Kingdom. Thomas Notter's co-authors include Frank Ruschitzka, Thomas F. Lüscher, Marvin A. Konstam, Inder S. Anand, John J.V. McMurray, Jay N. Cohn, Kurt Quitzau, Roland Willenbrock, Veselin Mitrović and Sebastian Philipp and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Thomas Notter

6 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Notter Germany 4 417 257 142 63 40 6 477
Konstantina Aggeli Greece 10 211 0.5× 196 0.8× 166 1.2× 89 1.4× 40 1.0× 48 426
Guichu Li United States 9 689 1.7× 128 0.5× 45 0.3× 72 1.1× 54 1.4× 11 776
Alex Shaknovich United States 4 503 1.2× 154 0.6× 39 0.3× 59 0.9× 88 2.2× 6 598
Harumi Katoh Japan 14 432 1.0× 150 0.6× 151 1.1× 153 2.4× 62 1.6× 31 600
George Kubac Canada 6 247 0.6× 76 0.3× 168 1.2× 58 0.9× 33 0.8× 11 355
D. J. O'Gorman United Kingdom 9 368 0.9× 126 0.5× 33 0.2× 65 1.0× 41 1.0× 10 451
Mathias Knecht United States 7 246 0.6× 38 0.1× 96 0.7× 42 0.7× 47 1.2× 13 330
Bunji Kaku Japan 11 225 0.5× 180 0.7× 42 0.3× 186 3.0× 90 2.3× 30 456
Lucienne S. Sanchez United States 7 125 0.3× 217 0.8× 143 1.0× 41 0.7× 92 2.3× 10 320
Yasushi Wakabayashi Japan 11 323 0.8× 123 0.5× 126 0.9× 92 1.5× 56 1.4× 52 492

Countries citing papers authored by Thomas Notter

Since Specialization
Citations

This map shows the geographic impact of Thomas Notter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Notter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Notter more than expected).

Fields of papers citing papers by Thomas Notter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Notter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Notter. The network helps show where Thomas Notter may publish in the future.

Co-authorship network of co-authors of Thomas Notter

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Notter. A scholar is included among the top collaborators of Thomas Notter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Notter. Thomas Notter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
2.
Mitrović, Veselin, Inder S. Anand, Thorsten Dill, et al.. (2004). 859-4 Nonterminal Pro B-type natriuretic peptide in patients with chronic heart failure: Correlation with B-type natriuretic peptide and left ventricular structure and function. Journal of the American College of Cardiology. 43(5). A235–A235. 1 indexed citations
3.
Philipp, Sebastian, Jan Monti, Ines Pagel, et al.. (2002). Treatment with darusentan over 21 days improved cGMP generation in patients with chronic heart failure. Clinical Science. 103(s2002). 249S–253S. 5 indexed citations
4.
Lüscher, Thomas F., Frank Enseleit, Richard Pacher, et al.. (2002). Hemodynamic and Neurohumoral Effects of Selective Endothelin A (ET A ) Receptor Blockade in Chronic Heart Failure. Circulation. 106(21). 2666–2672. 175 indexed citations
5.
Lüscher, Thomas F., Frank Ruschitzka, Inder S. Anand, et al.. (2001). EARTH: Endothelin<sub>A</sub> Receptor Antagonist Trial in Heart Failure. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 1(6). 294–298. 3 indexed citations
6.
Breithaupt‐Grögler, Kerstin, et al.. (1998). Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.. PubMed. 36(8). 425–31. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026